The Noguchi Memorial Institute for Medical Research (NMIMR) has taken a bold step in advancing biomedical research with the acquisition of the S8 FACS Discover Flow Cytometer and Molecular Suite. This state-of-the-art technology, the first of its kind in the sub-region, is set to revolutionize research in immunology, cancer, and infectious diseases.
At a ceremony to launch the equipment and suite, Professor Dorothy Yeboah-Manu, Director of Noguchi Memorial Institute for Medical Research, emphasized the significance of this acquisition in her welcome remarks.
She said this marks a transformative phase for biomedical research in Ghana and beyond. It aligns with the University of Ghana’s 2024–2029 Strategic Plan, which prioritizes impactful research, student transformation, and sustainable resource utilization.
Professor Alfred Edwin Yawson, Provost of the College of Health Sciences and Chairperson of the event, praised NMIMR for its continuous pursuit of excellence. He stated that “With the introduction of the S8 FACS Discover Flow Cytometer, NMIMR is poised to attract greater research collaborations and funding opportunities”
Professor David Dodoo-Arhin, Director of Research at the Research and Innovation Directorate (RID), University of Ghana reaffirmed the University’s commitment to advancing biomedical research in Ghana and the sub-region.
He commended the Institute for its leading role in research on Cancer, HIV, Malaria, and Tuberculosis (TB). He also highlighted the University’s focus on innovation, diversity, and inclusion as key drivers of scientific progress.
Professor Michael Fokuo Ofori, Head of the Department of Immunology, acknowledged NMIMR’s ability to acquire high-end research tools. He noted that this innovative equipment would significantly enhance studies in immunology, cancer, and infectious diseases.
Dr. Frederica Dedo Partey, a Research Fellow at the Department of Immunology and key member of the team manning the Flow Cytometer, delivered an insightful presentation on the advanced capabilities of the S8 FACS Discover Flow Cytometer. She detailed its high-precision cell analysis and sorting technology, which ensures unparalleled efficiency in biomedical research.
Dr. Dorothea Obiri, also a key member of the team manning the Flow Cytometer, elaborated on the establishment of the Flow Cytometry Core at NMIMR, emphasizing its multidisciplinary research potential. “This facility will foster cross-departmental collaboration and drive groundbreaking scientific discoveries,” she noted.
Representing BD Biosciences, the manufacturer of the S8 FACS Discover, Mrs. Christiana Acheampong expressed enthusiasm about their collaboration with NMIMR. “This is the first installation of its kind in the sub-region, and BD Biosciences is committed to supporting African researchers with world-class scientific tools,” she stated.
In his closing remarks, Professor Yawson encouraged researchers to leverage the new facility for transformative studies that could improve healthcare outcomes. He also stressed the importance of strategic collaborations and sustained funding to maximize the impact of this acquisition.
The event concluded with a guided tour of the facility during which a live demonstration of the S8 FACS Discover Flow Cytometer and Molecular Suite.
The introduction of the S8 FACS Discover Flow Cytometer and Molecular Suite marks a significant milestone in NMIMR’s efforts to advance biomedical research. This initiative not only enhances Ghana’s scientific capabilities but also strengthens its contribution to global healthcare advancements through innovative technology and research innovation.